CA ATRA 10MG CAPSULES

CA ATRA 10mg Capsules is a targeted therapy used in the treatment of acute promyelocytic leukemia (APL). It contains all-trans retinoic acid (ATRA), a vitamin A derivative that promotes the differentiation of immature leukemia cells into mature blood cells, helping reduce abnormal cell proliferation. This pharmaceutical product is prescribed under strict medical supervision for effective leukemia management.

CA ATRA 10 mg Capsules work by inducing maturation of leukemic promyelocytes, which helps restore normal blood cell function. It is commonly used in combination with other chemotherapeutic agents to achieve remission in patients with APL. Regular monitoring and adherence to the prescribed dosage ensure optimal treatment outcomes and minimize side effects.

CA ATRA 10mg Capsules guarantee purity, potency, and consistent therapeutic performance. These pharmaceutical products are among the leading products in leukemia care and are widely supplied to hospitals, oncology centers, and pharmacies, providing reliable and high-quality therapy for patients requiring targeted leukemia treatment.

Product Features

• Contains All-Trans Retinoic Acid (ATRA) 10mg
• Used for the treatment of acute promyelocytic leukemia (APL)
• Promotes differentiation of leukemia cells
• Oral targeted anticancer therapy
• High-quality pharmaceutical formulation

How It Helps

• Induces maturation of immature leukemia cells
• Reduces abnormal cell proliferation
• Supports remission in APL patients
• Enhances the effectiveness of combination chemotherapy